The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Changes In Market Value Are Expected For The In Vitro Cancer Diagnostics Market Over The 2026–2030 Period?
The in vitro cancer diagnostics market has demonstrated robust growth over recent years. It is projected to expand from $11.49 billion in 2025 to $12.36 billion by 2026, achieving a compound annual growth rate (CAGR) of 7.6%. This historical growth is largely due to factors such as increasing cancer prevalence, the widespread adoption of molecular diagnostics, the ongoing development of immunoassay kits, the expansion of diagnostic laboratories, and significant advancements in reagent technologies.
The in vitro cancer diagnostics market size is projected to experience substantial growth in the upcoming years, expanding to $16.78 billion by 2030 at a compound annual growth rate (CAGR) of 7.9%. This growth during the forecast period is attributable to several factors, including AI-enabled predictive analytics, the expansion of personalized oncology, the development of advanced high-throughput sequencing platforms, the increasing prevalence of point-of-care diagnostics, and the adoption of cloud-based diagnostic software. Key trends anticipated in the forecast period encompass biomarker-based detection, genetic profiling tools, multiplex assay development, integration with laboratory information systems (LIMS), and the widespread use of rapid diagnostic kits.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29090&type=smp
What Major Factors Are Driving The In Vitro Cancer Diagnostics Market Forward?
The in vitro cancer diagnostics market is anticipated to expand due to the increasing integration of liquid biopsy technologies. These technologies are defined as minimally invasive diagnostic approaches capable of identifying and examining biomarkers—including circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), or exosomes—found in bodily fluids like blood, urine, or saliva. Their purpose is to track the presence, progression, or treatment response of diseases, especially cancer. The development of liquid biopsy technologies is fueled by progress in the isolation and analysis of circulating tumor DNA and circulating tumor cells from various body fluids, including blood. The demand for in vitro cancer diagnostic solutions is escalating, driven by the rapid growth of liquid biopsy technologies, which encourages businesses to implement non-invasive, real-time molecular profiling instruments for detecting cancer and guiding its treatment. For example, NHS England, a public healthcare system in the UK, announced in May 2025 that the initial rollout of a novel liquid biopsy blood test in the UK is projected to annually assist up to 15,000 patients with suspected lung cancer and 5,000 women with advanced breast cancer. This initiative is set to rapidly expand from approximately 2,200 patients tested during the early 2025 phase to an estimated 20,000 patients yearly by 2028. Consequently, the growing acceptance of liquid biopsy technologies is a key factor boosting the demand within the in vitro cancer diagnostics market.
What Segment Categories Shape The In Vitro Cancer Diagnostics Market Segment Landscape?
The in vitro cancer diagnostics market covered in this report is segmented –
1) By Product Type: Kits, Instruments, Reagents, Software, Consumables
2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH), Immunohistochemistry, Other Technologies
3) By Application: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Other Applications
4) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Other End Users
Subsegments:
1) By Kits: Immunoassay Kits, Polymerase Chain Reaction (PCR) Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Flow Cytometry Kits
2) By Instruments: Polymerase Chain Reaction (PCR) Instruments, Sequencers, Flow Cytometers, Imaging Systems
3) By Reagents: Enzymes, Buffers, Probes, Stains
4) By Software: Data Analysis Software, Imaging Software, Laboratory Information Management System (LIMS) Software, Diagnostic Reporting Software
5) By Consumables: Microplates, Pipette Tips, Tubes, Slides
Which Trends Are Impacting The Progress Of The In Vitro Cancer Diagnostics Market?
Leading companies in the in vitro cancer diagnostics market are prioritizing the development of AI-powered cancer diagnostics to enhance patient care and advance personalized healthcare solutions. AI-driven cancer diagnostics involves the utilization of artificial intelligence to analyze medical and molecular data sourced from patient samples, imaging, or genetic tests, allowing for more accurate detection, diagnosis, and prediction of cancer. For example, in September 2024, Roche, a pharmaceutical company based in Switzerland, introduced the Digital Pathology Open Environment. This collaborative platform securely integrates advanced AI-based image analysis tools from both Roche and numerous third-party developers. The platform empowers pathologists to utilize innovative algorithms within Roche’s Navify Digital Pathology enterprise software, thereby improving diagnostic precision and workflow efficiency. By fostering collaboration and data sharing, this environment accelerates innovation in cancer diagnostics and research, supports precision medicine, and facilitates targeted treatments, ultimately expanding access to cutting-edge digital pathology tools globally.
Who Are The Companies Operating Across The In Vitro Cancer Diagnostics Market Value Chain?
Major companies operating in the in vitro cancer diagnostics market are F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers AG, Illumina Inc, Hologic Inc, Qiagen N.V, Bio-Rad Laboratories Inc, Agilent Technologies, Becton, Dickinson and Company (BD), Sysmex Corporation, LabCorp Holding Corp., Guardant Health, Quest Diagnostics, Exact Sciences, Myriad Genetics Inc, Natera Inc., NeoGenomics Laboratories, NanoString Technologies Inc, Caris Life Sciences, Transasia Bio-Medicals Ltd, Autobio Diagnostics Co Ltd, QuidelOrtho Corporation, Cancer Diagnostics Inc, Predicine Inc, Strata Oncology, Biocept Inc, Lucence Diagnostics
Get The Full In Vitro Cancer Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/report/in-vitro-cancer-diagnostics-global-market-report
Which Region Is The Top Contributor To The In Vitro Cancer Diagnostics Market By Share?
North America was the largest region in the in vitro cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized In Vitro Cancer Diagnostics Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=29090&type=smp
Browse Through More Reports Similar to the Global In Vitro Cancer Diagnostics Market 2026, By The Business Research Company
Cancer Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report
In Vitro Diagnostics Enzymes Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-enzymes-global-market-report
Bioinformatics In In Vitro Diagnostics Ivd Testing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model